As of 2025-10-20, the EV/EBITDA ratio of VBI Vaccines Inc (VBIV) is -0.00. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VBIV's latest enterprise value is 0.01 mil USD. VBIV's TTM EBITDA according to its financial statements is -45.59 mil USD. Dividing these 2 quantities gives us the above VBIV EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.6x - 18.3x | 16.4x |
| Forward P/E multiples | 28.6x - 45.5x | 40.8x |
| Fair Price | (8,502.97) - (5,454.29) | (8,514.88) |
| Upside | -13021491.1% - -8352757.1% | -13039728.4% |
| Date | EV/EBITDA |